Pyranoamentoflavone 7,4\'\'\'-dimethyl ether



Compound IDCDAMM01065
Common namePyranoamentoflavone 7,4\'\'\'-dimethyl ether
IUPAC name5-hydroxy-10-[2-hydroxy-5-(5-hydroxy-7-methoxy-4-oxochromen-2-yl)phenyl]-8-(4-methoxyphenyl)-2,2-dimethylpyrano[3,2-g]chromen-6-one
Molecular formulaC37H28O10

Experimental data

Retention time14.41
Adduct[M+H]+
Actual mz633.167
Theoretical mz633.175
Error12.75
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score5.4227

Identifiers and class information

Inchi keyUEZGSUUEYWENHE-UHFFFAOYSA-N
SmilesO=C1C=C(OC=2C=C(OC)C=C(O)C12)C=3C=CC(O)=C(C3)C4=C5OC(=CC(=O)C5=C(O)C=6C=CC(OC64)(C)C)C=7C=CC(OC)=CC7
SuperclassPhenylpropanoids and polyketides
ClassFlavonoids

Pharmacokinetic properties

Number of descriptor values(#stars)3
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)6
Number of reactive functional groups (#rtvFG)0
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)632.622
Computed dipole moment(dipole)7.745
Total solvent accessible surface area (SASA)931.654
Hydrophobic component of SASA (FOSA)307.44
Hydrophilic component of SASA (FISA)211.876
Pie component of the SASA (PISA)412.338
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1770.53
Number of hydrogen bond donors (donorHB)1
Number of hydrogen bond acceptors (accptHB)7.5
Free energy of solvation of dipole (dip^2/V)0.0338808
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0080502
Globularity descriptor (glob)0.759707
Predicted polarizability in cubic angstroms (QPpolrz)64.788
Predicted hexadecane/gas partition coefficient (QPlogPC16)19.534
Predicted octanol/gas partition coefficient (QPlogPoct)28.353
Predicted water/gas partition coefficient (QPlogPw)13.736
Predicted octanol/water partition coefficient (QPlogPo/w)6.267
Predicted aqueous solubility (QPlogS)-9.371
Conformation-independent predicted aqueous solubility (CIQPlogS)-11.207
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-7.387
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)96.979
Predicted brain/blood partition coefficient (QPlogBB)-2.246
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)39.726
Predicted skin permeability, log Kp (QPlogKp)-3.396
PM3 calculated ionization potential (IP(ev))8.829
PM3 calculated electron affinity (EA(eV))0.706
Number of likely metabolic reactions (#metab)5
Prediction of binding to human serum albumin (QPlogKhsa)1.661
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)73.282
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)148.501
Number of nitrogen and oxygen atoms (#NandO)10
Number of violations of Lipinski’s rule of five (RuleOfFive)2
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P02766TTRTransthyretinT86462SEA
P43166CA7Carbonic anhydrase VIIT37541SEA
P11926ODC1Ornithine decarboxylaseT60366SEA
P33527ABCC1Multidrug resistance-associated protein 1T11288SEA
P08183ABCB1P-glycoprotein 1T25258SEA
O14746TERTTelomerase reverse transcriptaseT86052SEA
P15692VEGFAVascular endothelial growth factor AT20761SEA
P60568IL2Interleukin-2T61698SEA
P49763PGFPlacenta growth factorT70792SEA
Q9UNQ0ABCG2ATP-binding cassette sub-family G member 2T56556SEA
Q9NPH5NOX4NADPH oxidase 4T29741SEA
P47989XDHXanthine dehydrogenaseT40954SEA
Q16678CYP1B1Cytochrome P450 1B1T92521SEA
P16152CBR1Carbonyl reductase [NADPH] 1T70518SEA
Q13332PTPRSReceptor-type tyrosine-protein phosphatase ST10147SEA
Q99417MYCBPMYCBP messenger RNAT37298SEA
P16220CREB1Cyclic AMP-responsive element-binding proteinT92098SEA
Q9UK17KCND3Voltage-gated potassium channel Kv4.3T74500SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T86462DI0026Amyloidosis[ICD-11: 5D00]P02766TTR
T60366DI0020African trypanosomiasis[ICD-11: 1F51]P11926ODC1
T11288DI0167Gout[ICD-11: FA25]P33527ABCC1
T25258DI0238Lung cancer[ICD-11: 2C25]P08183ABCB1
T86052DI0184Human immunodeficiency virus disease[ICD-11: 1C60-1C62]O14746TERT
T86052DI0284Myelodysplastic syndrome[ICD-11: 2A37]O14746TERT
T86052DI0326Pancreatic cancer[ICD-11: 2C10]O14746TERT
T20761DI0095Colorectal cancer[ICD-11: 2B91]P15692VEGFA
T20761DI0365Retinopathy[ICD-11: 9B71]P15692VEGFA
T20761DI0430Vascular system developmental anomaly[ICD-11: LA90]P15692VEGFA
T61698DI0275Multiple sclerosis[ICD-11: 8A40]P60568IL2
T61698DI0361Renal cell carcinoma[ICD-11: 2C90]P60568IL2
T70792DI0095Colorectal cancer[ICD-11: 2B91]P49763PGF
T56556DI0218Irritable bowel syndrome[ICD-11: DD91]Q9UNQ0ABCG2
T56556DI0366Rheumatoid arthritis[ICD-11: FA20]Q9UNQ0ABCG2
T29741DI0146Fibrosis[ICD-11: GA14-GC01]Q9NPH5NOX4
T40954DI0206Inborn purine/pyrimidine/nucleotide metabolism error[ICD-11: 5C55]P47989XDH
T40954DI0266Mineral deficiency[ICD-11: 5B5K]P47989XDH
T70518DI0037Asthma[ICD-11: CA23]P16152CBR1
T10147DI0057Bone paget disease[ICD-11: FB85]Q13332PTPRS
T37298DI0235Liver cancer[ICD-11: 2C12]Q99417MYCBP
T74500DI0004Acidosis[ICD-11: 5C73]Q9UK17KCND3

Copyright © 2025